Hematology Analyzers and Reagents Market by Products & Services, Price Range, End-user - Global Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hematology Analyzers and Reagents Market by Products & Services [Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology], Price Range (High, Low), End User (Government Labs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global hematology analyzers and reagents market is projected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9%.

Technological advancements in hematology analyzers and reagents, the integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain extent.

High-end hematology analyzers to be the fastest-growing segment during the forecast period.

By price range, the hematology instruments market is segmented into high-end, mid-range, and low-end hematology analyzers. The lower cost of these analyzers, in comparison with high-end analyzers, is a key factor driving the adoption of these instruments. Moreover, the smaller development, validation, and launch period for mid-range hematology analyzers (approximately two years) also contribute to overall market growth. As a result, several leading players are focused on the development of innovative technologies for mid-range hematology analyzers in the market

The Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The Asia Pacific is expected to register the highest growth rate during the forecast period due to the increasing geriatric population and the resultant growth in the incidence of thalassemia, sickle-cell anemia, and leukemia. Moreover, the improved healthcare infrastructure in countries like Japan, China, and Australia; rising number of general surgeries and organ transplantations; and the growing number of ongoing research activities are other factors also contributing to the high growth of this segment.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Hematology Analyzers and Reagents Market Overview

4.2 Hematology Analyzers and Reagents Market, by Product & Service

4.3 Hematology Analyzers and Reagents Market, by End User

4.4 Geographic Snapshot of the Hematology Analyzers and Reagents Market

5 Hematology Analyzers and Reagents Market, by Product & Service

5.1 Introduction

5.2 Hematology Products & Services

5.3 Hemostasis Products & Services

5.4 Immunohematology Products & Services

6 Hematology Analyzers Market, by Price Range

6.1 Introduction

6.2 Low-End Hematology Analyzers

6.3 High-End Hematology Analyzers

6.4 Mid-Range Hematology Analyzers

7 Hematology Analyzers and Reagents Market, by Application

7.1 Introduction

7.2 Hemorrhagic Conditions

7.3 Infection-Related Conditions

7.4 Immune System-Related Conditions

7.5 Blood Cancer

7.6 Anemia

7.7 Other Applications

8 Hematology Analyzers and Reagents Market, by Usage Type

8.1 Introduction

8.2 Standalone Analyzers

8.3 Point-Of-Care Analyzers

9 Hematology Analyzers and Reagents Market, by End User

9.1 Introduction

9.2 Commercial Service Providers

9.3 Hospital Laboratories

9.4 Government Reference Laboratories

9.5 Research & Academic Institutes

10 Hematology Analyzers and Reagents Market, by Region

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 Latin America

10.6 Middle East & Africa

11 Competitive Landscape

11.1 Overview

11.2 Market Share Analysis

11.3 Competitive Scenario

11.4 Competitive Leadership Mapping

12 Company Profiles

12.1 Roche

12.2 Abbott Laboratories

12.3 Danaher Corporation

12.4 Diatron

12.5 Drew Scientific Group

12.6 Siemens Healthineers Group

12.7 Sysmex Corporation

12.8 Bio-Rad Laboratories

12.9 Horiba

12.10 Nihon Kohden

12.11 EKF Diagnostics

12.12 Boule Diagnostics Ab

12.13 Mindray

12.14 Biosystems S.A. (A Ginper Group Company)

12.15 Ortho Clinical Diagnostics

12.16 Drucker Diagnostics

12.17 Vital Diagnostics

12.18 Accurex Biomedical Pvt. Ltd.

12.19 Carolina Liquid Chemistries

12.20 Neomedica Bioscience Technology

For more information about this report visit https://www.researchandmarkets.com/r/g0ffzv